Product Approval Information - Licensing Action
Proper name: Coagulation Factor IX (Recombinant)
Tradename: Benefix
Manufacturer: Genetics Institute, Inc, Andover, MA, License #1163
Indication for Use: For use in the control and prevention of hemorrhagic episodes in patients with hemophilia B, including the peri-operative management of hemophilia B patients undergoing surgery
Approval Date: 2/11/97
Type of submission: Biologics license application
Approval Letter - (PDF),
(Text)
SBA - (PDF)
Label - (PDF)
Talk Paper
|